| Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS Guideline Era JGE Zelt, J Sugarman, J Weatherald, ACR Partridge, JC Liang, J Swiston, ... European Respiratory Journal 59 (6), 2022 | 39 | 2022 |
| The combination of the R263K and T66I resistance substitutions in HIV-1 integrase is incompatible with high-level viral replication and the development of high-level drug … J Liang, T Mesplède, M Oliveira, K Anstett, MA Wainberg Journal of virology 89 (22), 11269-11274, 2015 | 28 | 2015 |
| Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs J Liang, E Nosova, H Reddon, S Nolan, E Socías, R Barrios, MJ Milloy AIDS (London, England) 34 (9), 1389, 2020 | 22 | 2020 |
| The R263K substitution in HIV-1 subtype C is more deleterious for integrase enzymatic function and viral replication than in subtype B T Mesplède, PK Quashie, S Hassounah, N Osman, Y Han, J Liang, ... Aids 29 (12), 1459-1466, 2015 | 22 | 2015 |
| The R263K dolutegravir resistance-associated substitution progressively decreases HIV-1 integration T Mesplède, J Leng, HT Pham, J Liang, Y Quan, Y Han, MA Wainberg MBio 8 (2), e00157-17, 2017 | 17 | 2017 |
| Diagnostic features in combined pulmonary fibrosis and emphysema: a systematic review AW Wong, J Liang, V Cottin, CJ Ryerson Annals of the American Thoracic Society 17 (10), 1333-1336, 2020 | 16 | 2020 |
| Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region L Melnychuk, L Ajamian, P Jean-Pierre, J Liang, R Gheorghe, ... Vaccine 35 (20), 2736-2744, 2017 | 5 | 2017 |
| Rivaroxaban-Associated Bullous Pemphigoid in a Patient With Atrial Fibrillation JC Liang, K Raman, SH Chan, AY Tashakkor CJC open 3 (10), 1316-1319, 2021 | 1 | 2021 |
| Association between the pulmonary artery pulsatility index and prognosis in pulmonary arterial hypertension: A multicenter study S Ostad, J Sugarman, A Alkhodair, J Liang, LM Mielniczuk, N Hambly, ... CJC Open, 2023 | | 2023 |
| Mechanistic classification and outcomes of isolated aortic regurgitation in a contemporary cohort of patients R Unni, J Liang, I Jelaidan, D Harnett, M Boodhwani, D Glineur, I Burwash, ... Archives of Cardiovascular Diseases Supplements 15 (1), 120, 2023 | | 2023 |
| Mechanistic Classification and Outcomes of Isolated Aortic Regurgitation in a Contemporary Cohort of Patients RR Unni, J Liang, I Jelaidan, D Harnett, M Boodhwani, D Glineur, ... Circulation 146 (Suppl_1), A14451-A14451, 2022 | | 2022 |
| PROGRESSION OF TRICUSPID REGURGITATION AND CLINICAL OUTCOMES IN PATIENTS WITH LONGSTANDING PERSISTENT ATRIAL FIBRILLATION J Liang, DF Yeung, C Luong, J Jue, K Gin, P Nair, TSM Tsang, ... Journal of the American College of Cardiology 79 (9_Supplement), 1683-1683, 2022 | | 2022 |
| The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration (vol 8, e00157-17, 2017) T Mesplede, J Leng, HT Pham, J Liang, Y Quan, Y Han, MA Wainberg MBIO 9 (5), 2018 | | 2018 |
| The R263K/H51Y resistance substitutions in HIV integrase decreases levels of integrated HIV DNA over time T Mesplede, N Osman, K Anstett, JC Liang, HT Pham, M Wainberg RETROVIROLOGY 13, 2016 | | 2016 |
| Selection of the R263K and H51Y resistance substitutions for DTG causes diminished integration and explains the lack of clinically significant drug resistance to this compound T Mesplède, J Liang, K Anstett, N Osman, HT Pham, MA Wainberg Journal of Virus Eradication 2, 27, 2016 | | 2016 |
| Primary resistance against dolutegravir decreases HIV integration T Mesplède, K Anstett, N Osman, S Hassounah, J Liang, Y Han, ... Journal of the International Aids Society 18, 2015 | | 2015 |
